Skip to main content
Open Forum Infectious Diseases logoLink to Open Forum Infectious Diseases
. 2019 Nov 10;6(12):ofz483. doi: 10.1093/ofid/ofz483

Predicting Carbapenem-Resistant Enterobacteriaceae Carriage at the Time of Admission Using a Statewide Hospital Discharge Database

Michael Y Lin 1,, Michael J Ray 2, Serena Rezny 3, Erica Runningdeer 3, Robert A Weinstein 1,2, William E Trick 1,2, CDC Prevention Epicenters Program
PMCID: PMC7047960  PMID: 32128328

Abstract

Background

Timely identification of patients likely to harbor carbapenem-resistant Enterobacteriaceae (CRE) can help health care facilities provide effective infection control and treatment. We evaluated whether a model utilizing prior health care information from a state hospital discharge database could predict a patient’s probability of CRE colonization at the time of hospital admission.

Methods

We performed a case–control study using the Illinois hospital discharge database. From a 2014–2015 patient cohort, we defined cases as index adult patient hospital encounters with a positive CRE culture collected within the first 3 days of hospitalization, as reported to the Illinois XDRO registry; controls were all patient admissions from the same hospital and month. We split the data into training (~60%) and validation (~40%) sets and developed a logistic regression model to estimate coefficients for predictors of interest.

Results

We identified 486 index cases and 340 005 controls. Independent risk factors for CRE at the time of admission were age, number of short-term acute care hospital (STACH) hospitalizations in the prior 365 days, mean STACH length of stay, number of long-term acute care hospital (LTACH) hospitalizations in the prior 365 days, mean LTACH length of stay, current admission to LTACH, and prior hospital admission with an infection diagnosis code. When applying the model to the validation data set, the area under the receiver operating characteristic curve was 0.84.

Conclusions

A prediction model utilizing prior health care exposure information could discriminate patients who were likely to harbor CRE at the time of hospital admission.

Keywords: antibiotic resistance, carbapenem resistance, prediction


Carbapenem-resistant Enterobacteriaceae (CRE) are extensively drug-resistant organisms (XDROs) of public health concern because of their ability to cause life-threatening infections and to spread in health care settings [1]. CRE are often brought into health care facilities by colonized patients, and facilities are encouraged to place CRE-colonized patients on isolation precautions to prevent patient-to-patient transmission. Because CRE colonization is usually asymptomatic, hospitals face the challenge of determining the CRE colonization status of patients at the time of admission [2]. As universal screening to detect colonization is costly, some facilities choose to test only those patients deemed “high risk,” often with limited knowledge of prior risk factors [3–6].

CRE carriage at the time of admission is strongly associated with prior intensity of health care facility exposure (particularly exposure to high-risk facilities such as long-term acute care hospitals) and prior antibiotic exposure [7–9]. However, data related to prior exposures involving external facilities typically reside outside a given hospital’s own information system and thus are inaccessible to hospital providers at the time of admission. State-based hospital discharge databases, which are increasingly available, contain historical patient-level health care exposures and diagnosis codes [10]. Such discharge data sets, which include infection-related diagnosis codes that are associated with prior antibiotic therapy [11], have the potential to inform models predicting risk of CRE carriage.

We hypothesized that the Illinois hospital discharge database could be used to develop a model to predict the probability of CRE colonization at the time of hospital admission. We leveraged the unique availability of the Illinois XDRO registry [12], which contains all reported CRE cases in the state, to train and validate our CRE prediction model.

METHODS

Model Development and Validation With 2014–2015 Patient Cohort

We performed a case–control study using data from 2 state-based databases: the Illinois hospital discharge database and the Illinois XDRO registry. The Illinois hospital database contains comprehensive encounter-level information for all Illinois hospitalizations in short-term acute care hospitals (STACHs) and long-term acute care hospitals (LTACHs) but excludes nonhospital settings such as skilled nursing facilities [10]. Hospital encounter data include patient identifiers, facility identifiers, and encounter characteristics (eg, dates of admission and discharge, diagnosis codes, and procedure codes). We classified hospitals as STACH or LTACH using the Illinois hospital database [13]. The Illinois XDRO registry (xdro.org) is a database of patients reported to the Illinois Department of Public Health as being colonized or infected with CRE; by rule, the first CRE-positive culture from each patient encounter must be reported to the registry. Reported information includes patient identifiers, date of admission, and date of positive CRE culture [12].

We defined index cases as adult (≥18 years of age) patient hospital encounters from January 1, 2014, to March 31, 2015, with a positive CRE culture collected within the first 3 days of hospitalization, as reported to the XDRO registry; only the first qualifying encounter per patient was analyzed. We defined controls as all patient admissions from the same hospital during the same month–year that an index case was reported; matching of controls by location and by time allowed us to account for confounding due to variation in the geographic distribution of CRE (which is unevenly distributed in Illinois) and potential temporal changes in CRE prevalence (ie, seasonal or secular trends).

For each hospital encounter, we determined the hospital type (STACH or LTACH) and the patient’s age at the time of admission. We determined the following health care exposures in the 365 days before each encounter: number of STACH hospitalizations, number of LTACH hospitalizations, average length of STACH stays in days, and average length of LTACH stays in days. As CRE-contaminated instruments used during endoscopic retrograde cholangiopancreatography (ERCP) have been previously identified as the source of a CRE outbreak in the Chicago region [14], we also determined whether a procedure code (ICD-9: 51.1X) indicating ERCP was present in the 365 days before each encounter. To infer prior antibiotic exposure, we assessed hospital encounters in the prior 365 days for which an infection diagnosis was recorded; prior hospital-associated infection diagnosis codes have been previously shown to be a surrogate for antibiotic exposure, particularly broad-spectrum antibiotics [11].

To develop and validate a prediction model for CRE carriage at the time of admission, we randomly split the data into training (~60%) and validation (~40%) sets. We developed a logistic regression model to estimate coefficients for predictors of interest that were chosen a priori because of their availability in the hospital discharge data set. The full model included the following predictors: age, sex, number of prior STACH and LTACH visits, mean prior STACH and LTACH lengths of stay, current hospital type (STACH vs LTACH), prior admission with infection diagnosis, and prior receipt of ERCP.

To guard against possible overfitting and improve the predictive capabilities of the model, we used a bootstrap aggregation (bagging) procedure [15]. To build the bagged model, we generated 100 random subsamples of cases and their corresponding controls from the training data set and used these subsamples to fit 100 logistic regressions with predictors of interest. We used each logistic regression to produce a set of predicted probabilities for the validation data set and then averaged these predicted probabilities. We used receiver operating characteristic curves based on the averaged predicted probabilities to evaluate the performance of the bagged model.

Although bagging approaches can improve prediction, it may be cumbersome, in practice, for hospitals to utilize a bagging approach and the multiple models entailed to predict CRE carriage at the time of admission. For this reason, we also fitted a single logistic regression model, without bagging, based on all cases and corresponding controls in the training data. The coefficients from this model for predictors of interest can be easily displayed and examined.

Application and Validation of Model in 2016 Cohort

To test the external validity (temporal stability) of our model, we applied the prediction model to a new cohort of adult (≥18 years of age) patients: those with hospitalizations in the Illinois hospital discharge database between January 1, 2016, and December 31, 2016. Diagnosis and procedure codes based on ICD-9 coding used in the original model were translated to ICD-10 codes using General Equivalence Mappings from the Centers for Medicare and Medicaid Services [16]. Using the parameter estimates from the model built, without bagging, on the training data from the first cohort, we generated predicted CRE probabilities for each patient encounter, then calculated each patient’s maximum CRE probability within the 2016 year. We stratified patients into the following CRE risk groups: 0%–5%, >5%–10%, >10%–20%, >20%–30%, >30%–40%, >40%–50%, and >50%. We then assessed how many patients within each risk stratum were reported as CRE-colonized to the XDRO registry during 2016. Because of the large number of patients in the 2 lowest strata for CRE risk, we randomly sampled 50 patients per stratum to estimate the CRE prevalence in those 2 groups. We used binomial methods to construct 95% confidence intervals.

All statistical tests were 2-sided, and P values of <.05 were considered statistically significant. Data were analyzed using SAS 9.4 (Cary, NC, USA) and R statistical software, version 3.1.2 (Vienna, Austria; http://www.R-project.org/).

RESULTS

Model Derivation and Validation Using the 2014–2015 Patient Cohort

In total, we identified 486 index cases (CRE-positive) and 340 005 control (CRE-negative) patient hospital encounters. Three hundred cases were selected for the training data set, and 186 were selected for the validation data set. Only those 143 278 controls in the training data who shared a hospital and month–year with one of the index cases in the training data were used to fit the models.

We compared patient characteristics of cases and their corresponding controls in the training set (Table 1). Cases tended to represent older patients who had more STACH and LTACH hospitalizations in the prior 365 days and a higher mean STACH and LTACH length of stay.

Table 1.

Adjusted Predictors of Carbapenem-Resistant Enterobacteriaceae Carriage on Admission, 2014–2015 Cohort

Covariatea Case (n = 300) Control (n = 143 278) aOR 95% CI P
Age, y 65 57 1.02 1.01–1.03 <.001
Male sex, % 50 42 1.07 0.85–1.35 .58
STACH hospitalizations in prior 365 d, No. 3.7 1.4 1.03 1.01–1.06 .02
Mean STACH length of stay, d 8.9 2.5 1.04 1.03–1.06 <.001
LTACH hospitalizations in prior 365 d, No. 0.5 0.02 2.32 1.94–2.78 <.001
Mean LTACH length of stay, d 11.1 0.3 1.02 1.02–1.03 <.001
Current facility is LTACH, % 20.3 1.0 5.80 4.15–8.12 <.001
Prior infection diagnosis, % 74 27 3.03 2.23–4.12 <.001
Prior ERCP, % 1.7 0.5 1.72 0.69–4.27 .24

Unless otherwise specified, case and control group means are presented. All predictors were obtained from data in the 365 days before a given patient’s admission, except for “Current facility is LTACH.” Odds ratios and P values are from a logistic regression model that included all covariates listed and an intercept.

Abbreviations: aOR, adjusted odds ratio; CI, confidence interval; ERCP, endoscopic retrograde cholangiopancreatography; LTACH, long-term acute care hospital; STACH = short-term acute care hospital.

The logistic regression model fit without bagging found the following variables to be independent risk factors for CRE at the time of admission (Table 1): age, number of STACH hospitalizations in the prior 365 days, mean STACH length of stay, number of LTACH hospitalizations in the prior 365 days, mean LTACH length of stay, current admission to LTACH, and prior hospital admission with an infection diagnosis. Applying the bagged logistic regression model to the validation data, we calculated the area under the receiver operating characteristic curve (AUC) to be 0.84 (Supplementary Appendix, Supplementary Table 1, and Supplementary Figure 1). When we restricted the training and validation data to STACH admissions only and fitted another bagged model, we calculated the AUC to be 0.81.

Model Application to 2016 Cohort

The 2016 cohort from the Illinois Hospital Discharge Database included 1 229 158 hospital visits by 816 500 unique adult patients; 38% of the patient hospital encounters were preceded by a prior hospitalization within 365 days. The full model predicted 1141 visits (745 patients) associated with a CRE risk >5%–10%, 572 visits (427 patients) with a >10%–20% risk, 144 visits (118 patients) with a >20%–30% risk, 81 visits (65 patients) with a >30%–40% risk, 53 visits (45 patients) with a >40%–50% risk, and 96 visits (63 patients) with a >50% risk.

Within each stratum, we estimated the actual CRE prevalence using XDRO registry reporting (Figure 1). In general, actual CRE prevalence increased in parallel with the predicted CRE risk. There appeared to be a ceiling effect of actual CRE prevalence; the predicted CRE prevalence was significantly greater than the actual CRE prevalence for the >50% stratum.

Figure 1.

Figure 1.

Predicted vs actual reported CRE colonization among Illinois patients in the 2016 validation cohort. Whiskers represent 95% confidence intervals. “Actual CRE-Positive” status refers to whether the patient was reported as CRE-positive to the XDRO registry. Abbreviations: CI, confidence interval; CRE, carbapenem-resistant Enterobacteriaceae.

DISCUSSION

We found that a model based on the information contained in a state hospital discharge database could discriminate patients who were likely to harbor CRE at the time of hospital admission. In particular, variables from the discharge database that captured prior frequency and duration of health care exposure and prior infection treatment (as a surrogate for antibiotic receipt) were found to be independent predictors of CRE carriage. Applying the prediction model could effectively risk-stratify patients and, if incorporated into an automated alerting system, could efficiently guide infection prevention efforts, such as active surveillance and preemptive isolation precautions.

The current strategies to identify patients at high risk of CRE or other multidrug-resistant organism carriage are not efficient. For example, hospitals may choose to screen patients directly transferred from other hospitals including LTACHs [3, 7], but such a strategy would miss patients with indirect health care exposures (ie, exposed to an LTACH but discharged to home before current admission). Another strategy that has been used to assess the risk of multidrug-resistant organism carriage is patient self-report of prior health care exposure [17–20], but this strategy requires relatively simplistic questions, accurate recall by patients, and hospital staff time to ask questions. Although electronic prediction models have been developed to identify patients at risk for certain multidrug-resistant organisms, data for such models are typically limited to the medical records of the admitting hospital system [21, 22]. Our current prediction model makes use of medical information in the year before admission from a statewide hospital discharge database and could be automated, such that infection control personnel could receive an electronic alert at the time of a patient’s admission.

An automated infrastructure for alerting health care facilities regarding the admission of patients who have laboratory-confirmed CRE history previously reported to the XDRO registry already exists in Illinois within the XDRO registry framework [12]. Such information-sharing is permitted under the Health Insurance Portability and Accountability Act’s Privacy Rule exemptions for public health to control the spread of a communicable disease [23]. Although there may be uncertain precedent for public health authorities to share patient health care information that is driven by risk-based rather than confirmed disease status, hospitals already make risk-based infection control decisions based on prior health care exposures, such as implementing screening or preemptive isolation precautions based on prior post–acute care facility exposure or exposure to high-risk geographic regions [3, 24–26].

Our model’s current prediction capability could be used to guide not only infection control measures, but also treatment. For example, a patient admitted with a high CRE risk score and diagnosed with suspected bacterial sepsis could receive empiric antibiotic treatment that would be active against CRE. Furthermore, although the current prediction model is calibrated for CRE, it may also provide risk stratification for other multidrug-resistant organisms that share similar risk factors. Prior exposure to health care and antibiotics are common risk factors for carriage of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and extended-spectrum beta-lactamase–producing organisms, and co-colonization is common [8, 22, 27–31]. The ability of the current prediction model to predict carriage of non-CRE multidrug-resistant pathogens warrants further investigation.

There are limitations to this study. First, this model was calibrated on patients who were reported to the Illinois XDRO registry as CRE-positive. Because asymptomatic and unrecognized CRE carriage occurs and because the XDRO registry is a passive surveillance system, under-reporting of CRE-colonized patients is possible. The presence of patients who were CRE-colonized but unreported would lead to misclassification bias toward the null and could explain, in part, the ceiling effect seen in the 2016 cohort validation, where predicted CRE risk diverged from actual CRE reports. Second, hospital discharge databases are comprehensive but rely on hospital report and lag by several months in Illinois. Our retrospective analyses used nonlagged health care exposure information at the time of discharge, but prospective implementation of such a model would be compromised by missing data or would require improvement in the timeliness of the data source. Third, the hospital discharge database does not contain skilled nursing facility exposures. Such exposures have been associated with carriage of multidrug-resistant organisms, including CRE [32, 33]. Lastly, our model is calibrated to the epidemiology of CRE in Illinois and needs validation in other geographic regions. As we began with an already limited set of available covariates with biological plausibility for predicting CRE carriage, we favored retaining the full model for our validation; however, in other geographic regions, some predictors such as prior ERCP may not be needed to maintain model performance.

Despite these limitations, our study has several strengths. The Illinois XDRO registry represents one of the largest cohorts of CRE carriers available for modeling. The modeling parameters estimated in this study have biologic plausibility and are consistent with risks of CRE colonization that have been described in other geographic regions with CRE transmission [26, 34–39].

In summary, we demonstrated that a CRE prediction model informed by routinely available health care exposure data in a state hospital discharge database can effectively predict the CRE status of patients at the time of admission. Such a model could provide timely, actionable information to front-line providers to improve the care of patients at risk of CRE infection.

Supplementary Data

Supplementary materials are available at Open Forum Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.

ofz483_suppl_Supplementary_Material

Acknowledgments

We thank Dejan Jovanov for his assistance with data extraction and data preparation for analysis.

Financial support. This work was supported by the Centers for Disease Control and Prevention (grant numbers 5U54CK000161 and U54CK000161-05S1 to R.A.W.; grant number 1U54CK000481 to W.E.T.).

Potential conflicts of interest. M.Y.L. has received research support in the form of contributed product from OpGen and Sage Products (now part of Stryker Corporation) and has received an investigator-initiated grant from CareFusion Foundation (now part of BD). R.A.W. has received research support in the form of contributed product from Clorox, Medline, Molnlycke, and Sage Products. W.E.T. has received an investigator-initiated grant from CareFusion Foundation. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Prior presentation. Presented in part at IDWeek 2016 (New Orleans) and IDWeek 2018 (San Francisco).

References

  • 1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60–7. [DOI] [PubMed] [Google Scholar]
  • 2. CDC. 2015 CRE Toolkit - guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) Available at: http://www.cdc.gov/hai/organisms/cre/cre-toolkit/. Accessed 8 April 2016.
  • 3. Shimasaki T, Segreti J, Tomich A, et al. . Active screening and interfacility communication of carbapenem-resistant Enterobacteriaceae (CRE) in a tertiary-care hospital. Infect Control Hosp Epidemiol 2018; 39(9):1058–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ben-David D, Maor Y, Keller N, et al. . Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010; 31:620–6. [DOI] [PubMed] [Google Scholar]
  • 5. Kochar S, Sheard T, Sharma R, et al. . Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009; 30:447–52. [DOI] [PubMed] [Google Scholar]
  • 6. Calfee D, Jenkins SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 2008; 29:966–8. [DOI] [PubMed] [Google Scholar]
  • 7. Prabaker K, Lin MY, McNally M, et al. ; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012; 33:1193–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. . Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012; 67:2976–81. [DOI] [PubMed] [Google Scholar]
  • 9. Tumbarello M, Trecarichi EM, Tumietto F, et al. . Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2014; 58(6):3514–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Illinois Department of Public Health. Patient safety and quality: discharge data Available at: http://dph.illinois.gov/topics-services/prevention-wellness/patient-safety-quality/discharge-data. Accessed 30 August 2018.
  • 11. Ray MJ, Trick WE, Lin MY. Assessing the ability of hospital diagnosis codes to detect inpatient exposure to antibacterial agents. Infect Control Hosp Epidemiol 2018; 39:377–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Trick WE, Lin MY, Cheng-Leidig R, et al. . Electronic public health registry of extensively drug-resistant organisms, Illinois, USA. Emerg Infect Dis 2015; 21:1725–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Illinois Department of Public Health. Individual hospital profiles by hospital name, 2014 Available at: https://www2.illinois.gov/sites/hfsrb/inventoriesdata/facilityprofiles/pages/default.aspx. Accessed 29 October 2018.
  • 14. Epstein L, Hunter JC, Arwady MA, et al. . New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014; 312:1447–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Breiman L. Bagging predictors. Mach Learn 1996; 24:123–40. [Google Scholar]
  • 16. Centers for Medicare & Medicaid Services. 2018 general equivalence mappings Available at: https://www.cms.gov/Medicare/Coding/ICD10/2018-ICD-10-CM-and-GEMs.html. Accessed 29 October 2018.
  • 17. Furuno JP, McGregor JC, Harris AD, et al. . Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006; 166:580–5. [DOI] [PubMed] [Google Scholar]
  • 18. Riedel S, Von Stein D, Richardson K, et al. . Development of a prediction rule for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus carriage in a Veterans Affairs Medical Center population. Infect Control Hosp Epidemiol 2008; 29:969–71. [DOI] [PubMed] [Google Scholar]
  • 19. Harbarth S, Sax H, Uckay I, et al. . A predictive model for identifying surgical patients at risk of methicillin-resistant Staphylococcus aureus carriage on admission. J Am Coll Surg 2008; 207:683–9. [DOI] [PubMed] [Google Scholar]
  • 20. Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, et al. . Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect 2015; 21:141–6. [DOI] [PubMed] [Google Scholar]
  • 21. Robicsek A, Beaumont JL, Wright MO, et al. . Electronic prediction rules for methicillin-resistant Staphylococcus aureus colonization. Infect Control Hosp Epidemiol 2011; 32:9–19. [DOI] [PubMed] [Google Scholar]
  • 22. Morgan DJ, Day HR, Furuno JP, et al. . Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission. Infect Control Hosp Epidemiol 2010; 31:1230–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. United States Department of Health and Human Services. Disclosures for public health activities Available at: https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/disclosures-public-health-activities/index.html. Accessed 30 August 2018.
  • 24. Centers for Disease Control and Prevention. Investigation of carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients at a community hospital—Kentucky, 2016. Ann Emerg Med 2018; 72:59–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. Country-to-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis 2011; 53:49–56. [DOI] [PubMed] [Google Scholar]
  • 26. Bhargava A, Hayakawa K, Silverman E, et al. . Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014; 35:398–405. [DOI] [PubMed] [Google Scholar]
  • 27. McKinnell JA, Miller LG, Eells SJ, et al. . A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013; 34:1077–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Marchaim D, Gottesman T, Schwartz O, et al. . National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2010; 54:5099–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Tumbarello M, Trecarichi EM, Bassetti M, et al. . Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 2011; 55:3485–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Harris AD, McGregor JC, Johnson JA, et al. . Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 2007; 13:1144–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Marchaim D, Perez F, Lee J, et al. . “Swimming in resistance”: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control 2012; 40:830–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Lin MY, Froilan MC, Lolans K, et al. . The importance of ventilator skilled nursing facilities (vSNFs) in the regional epidemiology of carbapenemase-producing organisms (CPOs). Open Forum Infect Dis 2017; 4(Suppl 1): S137–S8. [Google Scholar]
  • 33. Prabaker K, Lin MY, McNally M, et al. ; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012; 33:1193–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013; 34:144–50. [DOI] [PubMed] [Google Scholar]
  • 35. Perez F, Endimiani A, Ray AJ, et al. . Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 2010; 65:1807–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Urban C, Bradford PA, Tuckman M, et al. . Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities. Clin Infect Dis 2008; 46:e127–30. [DOI] [PubMed] [Google Scholar]
  • 37. Swaminathan M, Sharma S, Poliansky Blash S, et al. . Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013; 34:809–17. [DOI] [PubMed] [Google Scholar]
  • 38. Han JH, Goldstein EJ, Wise J, et al. . Epidemiology of carbapenem-resistant Klebsiella pneumoniae in a network of long-term acute care hospitals. Clin Infect Dis 2016; 64:839–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Ben-David D, Masarwa S, Adler A, et al. . A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals. Infect Control Hosp Epidemiol 2014; 35:802–9. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ofz483_suppl_Supplementary_Material

Articles from Open Forum Infectious Diseases are provided here courtesy of Oxford University Press

RESOURCES